Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

AI-Assisted Interpretation of Ultra-Widefield Retinal Images

10 de junho de 2026 atualizado por: XiujuChen, Xiamen Ophthalmology Center Affiliated to Xiamen University

Prospective Multi-Center Evaluation of AI-Assisted Interpretation of Ultra-Widefield Retinal Images in a Multi-Reader Crossover Study

The goal of this prospective observational study is to evaluate the impact of artificial intelligence (AI) assistance on clinician interpretation of ultra-widefield (UWF) retinal images.

The main questions it aims to answer are:

whether AI assistance improves the diagnostic performance of ophthalmologists in detecting retinal findings on UWF retinal images; whether AI assistance improves sensitivity, specificity, and inter-reader agreement across clinicians with different levels of experience.

Approximately 600 UWF retinal images prospectively collected from multiple ophthalmic centers in China will be included. Images will be independently annotated by expert retinal specialists to establish reference labels for retinal finding categories.

Four ophthalmologists with different levels of clinical experience, including one senior retinal specialist and three junior ophthalmologists, will participate in a crossover multi-reader study.

For each clinician, the dataset will be randomly divided into two equal subsets. During the first reading session, clinicians will evaluate one subset without AI assistance and the other subset with AI assistance. After a washout interval of at least two weeks, the reading conditions will be reversed in a second reading session with independently randomized image order.

Under the AI-assisted condition, clinicians will be provided with category-level AI prediction probabilities for retinal findings. No localization maps, heatmaps, segmentation overlays, or automated diagnostic recommendations will be displayed. Clinicians will retain full autonomy over final decisions.

Reader performance under AI-assisted and unaided conditions will be compared using expert reference annotations as the ground truth.

Visão geral do estudo

Descrição detalhada

This study is a prospective multi-center observational reader study designed to evaluate the impact of artificial intelligence (AI) assistance on clinician interpretation of ultra-widefield (UWF) retinal images.

Approximately 600 UWF retinal images will be prospectively collected from multiple ophthalmic centers in China. Images will be acquired using clinically routine UWF retinal imaging systems and will include a broad spectrum of retinal diseases and retinal findings encountered in real-world clinical practice.

All images will undergo independent expert annotation by retinal specialists to establish reference labels for retinal finding categories. These expert annotations will serve as the reference standard for subsequent performance evaluation.

Four ophthalmologists with different levels of clinical experience will participate in the reader study, including:

one senior retinal specialist with approximately five years of retinal clinical experience; three junior ophthalmologists with approximately two years of ophthalmology residency training.

A randomized crossover multi-reader design will be implemented to minimize recall bias and balance reading conditions.

For each clinician, the image dataset will be randomly divided into two equal subsets (subset A and subset B; approximately 300 images each).

During Round 1:

subset A will be interpreted without AI assistance; subset B will be interpreted with AI assistance.

After a washout interval of at least two weeks, the reading conditions will be reversed during Round 2:

subset A will be interpreted with AI assistance; subset B will be interpreted without AI assistance.

Image order will be independently randomized for each session and each clinician.

Under the unaided condition, clinicians will evaluate retinal images using standard clinical interpretation without AI output.

Under the AI-assisted condition, clinicians will receive category-level AI prediction probabilities for retinal finding categories. The AI output will provide probabilistic confidence scores only and will not include lesion localization maps, heatmaps, segmentation overlays, or automated binary recommendations.

Clinicians will remain blinded to the expert reference labels and to the interpretations of other readers. Final diagnostic decisions will be independently determined by each clinician.

The primary analysis will compare diagnostic performance between unaided and AI-assisted conditions, including sensitivity, specificity, area under the receiver operating characteristic curve (AUC), and inter-reader agreement.

Tipo de estudo

Observacional

Inscrição (Real)

462

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, China
        • Chongqing Huaxia Eye Hospital
    • Fujian
      • Fuzhou, Fujian, China, 361000
        • Fuzhou Eye Hospital
      • Xiamen, Fujian, China, 361000
        • Xiamen Eye Center of Xiamen University
    • Hebei
      • Hengshui, Hebei, China
        • Hengshui Tongrui Eye Hospital
    • Shandong
      • Heze, Shandong, China
        • Heze Huaxia Eye Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Método de amostragem

Amostra Não Probabilística

População do estudo

Participants undergoing clinically indicated ultra-widefield retinal imaging at participating ophthalmic centers in China, including individuals with diverse retinal diseases and retinal findings encountered in real-world clinical practice.

Descrição

Inclusion Criteria:

  • Participants undergoing ultra-widefield retinal imaging at participating ophthalmic centers;

Exclusion Criteria:

  • Poor-quality or ungradable retinal images;

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
AI-Assisted Interpretation
Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.
Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.
Unaided Interpretation
Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.
Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Sensitivity for retinal finding detection
Prazo: through study completion, an average of 2 months
Sensitivity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions using expert annotations as the reference standard.
through study completion, an average of 2 months
Specificity for retinal finding detection
Prazo: through study completion, an average of 2 months
Specificity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions.
through study completion, an average of 2 months

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Area under the receiver operating characteristic curve (AUC)
Prazo: through study completion, an average of 2 months
The AUC quantifies the overall ability to correctly distinguish the presence versus absence of predefined retinal findings on ultra-widefield retinal images. AUC values range from 0.5 (no discriminative ability) to 1.0 (perfect discrimination). Clinician interpretations will be compared with an expert-adjudicated reference standard under AI-assisted and unaided conditions.
through study completion, an average of 2 months
Inter-reader agreement
Prazo: At study completion (up to 3 months)
Agreement among participating clinicians in classifying predefined retinal findings on ultra-widefield retinal images. Agreement will be quantified using Cohen's kappa coefficient (for pairwise comparisons) or Fleiss' kappa coefficient (for multiple readers). Kappa values range from 0 (no agreement beyond chance) to 1 (perfect agreement).
At study completion (up to 3 months)
Diagnostic performance improvement among junior ophthalmologists
Prazo: At study completion (up to 3 months)
Improvement in diagnostic performance of junior ophthalmologists when interpreting ultra-widefield retinal images with AI assistance compared with unaided interpretation, measured by changes in sensitivity, specificity, accuracy, and AUC using the expert-adjudicated reference standard.
At study completion (up to 3 months)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Xiuju Chen, Xiamen Eye Center of Xiamen University

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de janeiro de 2026

Conclusão Primária (Real)

1 de fevereiro de 2026

Conclusão do estudo (Real)

10 de fevereiro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

5 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

10 de junho de 2026

Primeira postagem (Real)

16 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

10 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • XMYKZX-KY-2026-008

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

De-identified individual participant data underlying the results reported in this study, including retinal imaging data and associated annotations, may be made available upon reasonable request to the corresponding investigator following publication, subject to institutional ethics approval, data-sharing agreements, and applicable data governance and privacy regulations.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever